Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Surgery claims stoke NHS investment debate

This article was originally published in Clinica

Executive Summary

The £8bn ($15.8bn) extra funding going to the NHS in England and Wales this year will provide for an additional 390,000 operations and a range of quality initiatives, according to the UK Department of Health. The Local spending for local needs report released today seeks to deflect criticism that the budget increases designed to make up for historic NHS under-investment have been largely misspent. Leading healthcare figures have been vocal in their discontent (see above).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT048383

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel